Long-term residual cardiovascular risk after acute coronary syndrome: antithrombotic treatment options

D. R. P. P. Chan Pin Yin, J.M. ten Berg*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

1 Citation (Web of Science)
Original languageEnglish
Pages (from-to)38-46
Number of pages9
JournalNetherlands Heart Journal
Volume30
Issue number1
Early online date6 Aug 2021
DOIs
Publication statusPublished - Jan 2022

Keywords

  • Acute coronary syndrome
  • Antithrombotic therapy
  • Ischaemic risk
  • Myocardial infarction
  • DUAL-ANTIPLATELET THERAPY
  • MYOCARDIAL-INFARCTION
  • SECONDARY PREVENTION
  • STENT IMPLANTATION
  • COST-EFFECTIVENESS
  • BLEEDING RISKS
  • ARTERY-DISEASE
  • RIVAROXABAN
  • TICAGRELOR
  • DURATION

Cite this